VAXX
Income statement / Annual
Last year (2023), Vaxxinity, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Vaxxinity, Inc.'s net income was -$56,934.00.
See Vaxxinity, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$66,000.00
|
$557,000.00
|
$0.00
|
| Cost of Revenue |
$2.23 M |
$1.68 M |
$1.94 M |
$52,000.00 |
$107,000.00 |
| Gross Profit |
-$2.23 M |
-$1.68 M |
-$1.87 M |
$505,000.00 |
-$107,000.00 |
| Gross Profit Ratio |
0 |
0 |
-28.35 |
0.91 |
0 |
| Research and Development
Expenses |
$33.67 M
|
$47.63 M
|
$71.38 M
|
$20.57 M
|
$10.66 M
|
| General & Administrative
Expenses |
$22.39 M
|
$28.35 M
|
$51.83 M
|
$12.22 M
|
$3.01 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$22.39 M
|
$28.35 M
|
$51.83 M
|
$12.22 M
|
$3.01 M
|
| Other Expenses |
$0.00 |
$0.00 |
-$8.37 M |
-$5.76 M |
-$27,000.00 |
| Operating Expenses |
$56.05 M |
$75.98 M |
$123.20 M |
$32.79 M |
$13.66 M |
| Cost And Expenses |
$58.29 M |
$75.98 M |
$125.14 M |
$32.84 M |
$13.66 M |
| Interest Income |
$2.09 M |
$1.26 M |
$9,000.00 |
$1,000.00 |
$435,000.00 |
| Interest Expense |
$696,000.00 |
$514,000.00 |
$840,000.00 |
$1.18 M |
$435,000.00 |
| Depreciation &
Amortization |
$2,234.00
|
$1.68 M
|
$1.10 M
|
$717,000.00
|
$107,000.00
|
| EBITDA |
-$56,051.00
|
-$74.30 M
|
-$135.23 M
|
-$31.57 M
|
-$13.58 M
|
| EBITDA Ratio |
0 |
0 |
-1878.24 |
-67.01 |
0 |
| Operating Income Ratio
|
0
|
0
|
-1895.08
|
-57.96
|
0
|
| Total Other
Income/Expenses Net |
$58.23 M
|
$757,000.00
|
-$12.10 M
|
-$7.68 M
|
-$502,000.00
|
| Income Before Tax |
-$56,934.00 |
-$75.22 M |
-$137.18 M |
-$39.96 M |
-$14.16 M |
| Income Before Tax Ratio
|
0
|
0
|
-2078.41
|
-71.74
|
0
|
| Income Tax Expense |
-$56,934.00 |
-$12,000.00 |
$840,000.00 |
-$4.58 M |
$56,000.00 |
| Net Income |
-$56,934.00 |
-$75.21 M |
-$138.02 M |
-$35.38 M |
-$14.22 M |
| Net Income Ratio |
0 |
0 |
-2091.14 |
-63.51 |
0 |
| EPS |
-0.45 |
-0.6 |
-1.1 |
-0.28 |
-0.11 |
| EPS Diluted |
-0.45 |
-0.6 |
-1.1 |
-0.28 |
-0.11 |
| Weighted Average Shares
Out |
$126,509.00
|
$125.94 M
|
$125.39 M
|
$125.45 M
|
$125.45 M
|
| Weighted Average Shares
Out Diluted |
$126,508.00
|
$125.94 M
|
$125.39 M
|
$125.45 M
|
$125.45 M
|
| Link |
|
|
|
|
|
